Most Recent
Ex-Aristocrat design head to pay up for copying docs containing trade secrets
Gaming giant Aristocrat has settled a suit brought against its former head of design, who admitted to copying a "substantial" number of documents containing the company's sensitive trade secrets.
Treasury Wine to pay $65M to settle long-running class action
Treasury Wine Estates has agreed to pay $65 million to settle a shareholder class action that was set down for a seven-week trial beginning Monday.
Flex commissions class action against ANZ settles for $85M
A class action against ANZ over alleged predatory lending practices has settled for $85 million, while two related cases against Westpac and Macquarie are set to go to trial this month.  
ANZ, OnePath to pay $50M in super class action settlement
Big Four bank ANZ and superannuation trustee OnePath will pay $50 million to settle a class action brought on behalf of super members allegedly charged excessive fees.
ANZ, OnePath reach 11th-hour settlement in class action
A settlement has been reached on the eve of trial in a class action against ANZ and OnePath alleging they slugged super fund members with excessive fees.
Merivale reaches new class action settlement after first deal scrapped
Hospitality giant Merivale has reached a revised settlement in an employment class action, five months after the lead applicant's unusual move to renege on an earlier deal.
Appeal filed to set aside $112M Robodebt class action settlement
An appeal is seeking to set aside the $112 million Robodebt class action settlement to bring new claims on the back of damning revelations in a royal commission report.
PNG lawyer settles defamation case against ABC over $117M fraud allegations
Lawyer Samson Jubi has settled his defamation case against the ABC over stories he claims accused him of defrauding $117 million meant to benefit villagers after PNG’s largest mine disaster. 
Ex-AMP exec settles defamation suit against The Australian publisher
AMP’s former head of advice has settled defamation proceedings over a story in The Australian that suggested he misled ASIC during the banking royal commission. 
Mesoblast reaches settlement in class action over COVID-19 treatment
Mesoblast has agreed to settle a shareholder class action centred on statements to the market about its Remestemcel-L treatment, resolving claims it misrepresented the efficacy of the therapy for COVID-19 patients.